✦ LIBER ✦

CD21+ (B2 antigen+) cell decrement and CD4+ CD29+ (helper-inducer) cell increment suggest an activation of cell immune reactivity in multiple sclerosis

✍ Scribed by D. Gambi; A.M. Porrini; A. Giampietro; S. Macor

Book ID: 119107675
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 468 KB
Volume: 33
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(91)90053-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A T cell activation antigen, Ly6C, induc

A T cell activation antigen, Ly6C, induced on CD4+ Th1 cells mediates an inhibitory signal for secretion of IL-2 and proliferation in peripheral immune responses

✍ Sachiko Yamanouchi; Kazuhiko Kuwahara; Atsuko Sakata; Taichi Ezaki; Shuji Matsuo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views

CD30 Antigen and Multiple Sclerosis: CD3

CD30 Antigen and Multiple Sclerosis: CD30, an Important Costimulatory Molecule and Marker of a Regulatory Subpopulation of Dendritic Cells, Is Involved in the Maintenance of the Physiological Balance between TH1/TH2 Immune Responses and Tolerance

✍ Pellegrini, Patrizia; Totaro, Rocco; Contasta, Ida; Berghella, Anna Maria; Carol 📂 Article 📅 2005 🏛 S. Karger AG 🌐 English ⚖ 188 KB

CD30 Antigen and Multiple Sclerosis: CD3

✍ Pellegrini, Patrizia; Totaro, Rocco; Contasta, Ida; Berghella, Anna Maria; Carol 📂 Article 📅 2005 🏛 S. Karger AG 🌐 English ⚖ 188 KB

__Objectives:__ The immunological effect of CD30 on dendritic cells (DCs) was examined in a comparative study of patients with relapsing-remitting multiple sclerosis (RRMS). The patients were divided into two groups on the basis of interferon (IFN)β-1a treatment: IFNβ-1a-treated patients and untreat